FdaApplication
ANDA 219604
Identifiers
- fda_app_no: ANDA219604
Properties
| Property | Value |
|---|---|
| applicant_name | BE PHARMACEUTICALS AG |
| application_type | ANDA |
| approval_date | 2026-06-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DALBAVANCIN HYDROCHLORIDE | DALBAVANCIN HYDROCHLORIDE | EQ 500MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product